The author has ME.
"
6 February 2018 — 11:00pm
As recently as 1921, MS (multiple sclerosis) was erroneously considered more common in men. By the late 1940s, a more even gender split was presumed. By 1960 it was posited that women might actually be slightly more prone to the condition. With the...
Lacking the resources to write more -- just would like to let you know how the German Patient Organisation for MS "AMSEL" handles the issue of false (psycho-) perceptions of illness related fatigue.
Apologies for the Google translation (always funny though) - hope the key message is not lost...
foxp3 is relevant for MS could other fox genes be relevant for me/cfs I never see this mentioned and think it might be worth a look
https://multiplesclerosisnewstoday.com/2017/07/07/foxp3-gene-mutations-may-cause-aggressive-immune-system-responses-in-multiple-sclerosis-other-diseases/...
For those interested in these things this is a useful review (and hypothesis) of possible mechanisms for 'central fatigue' in MS and other neurological disorders (full paper).
Not directly relevant to ME/CFS although several ME/CFS studies are referenced.
Possibly the most interesting (and...
This article was from a few months ago, but I just saw it. It's about multiple sclerosis, but perhaps something useful can be gleaned from it.
Original article: http://www.nejm.org/doi/10.1056/NEJMoa1608889
Is anyone aware of any minocycline studies for ME/CFS?
Just thought this was interesting.
http://neurosciencenews.com/multiple-sclerosis-computer-simulation-7828/
Full open access at http://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1005757
e
I don't think this has much interest for ME because they are talking about repairing Myelin. But I think it is a good example of drug re purposing.
https://www.ucsf.edu/news/2017/10/408646/allergy-drug-improves-function-patients-chronic-injury-multiple-sclerosis
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.